Live Breaking News & Updates on Monopar Therapeutics Inc

Stay updated with breaking news from Monopar therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Jonestrading

Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) was upgraded by equities researchers at Jonestrading from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a $2.00 target price on the stock. Jonestrading’s price objective indicates a potential upside of 226.80% […] ....

United States , Windsor Advisory Group , Monopar Therapeutics Inc , Monopar Therapeutics , Get Free Report , Advisory Group , Free Report , Therapeutics Inc , Monopar Therapeutics Daily , Nasdaq Mnpr ,

Monopar Therapeutics (MNPR) Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

Monopar Therapeutics (MNPR) Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rodney Hicks , Chandler Robinson , Melbourne Theranostic Innovation Centre , Monopar Therapeutics Inc , Monopar Therapeutics , Professor Rodney Hicks , Siemens Biograph Vision Quadra , Chief Executive ,

Baystreet.ca - Monopar Shares Cheer Trial Results

Monopar Therapeutics Inc. (NASDAQ: MNPR) shares pick up ground Wednesday. The Wilmette, Illinois-based company, a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that its Phase . ....

United States , Rodney Hicks , Monopar Therapeutics Inc , Melbourne Theranostic Innovation Centre , Monopar Therapeutics , Professor Rodney Hicks , Siemens Biograph Vision Quadra ,

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments

WILMETTE, Ill., March 28, 2024 Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced fourth. ....

Monopartx Linkedin , Kimr Tsuchimoto , Rodney Hicks , Exchange Commission , Radiopharmaceutical Program , Monopar Therapeutics Inc , Melbourne Theranostic Innovation Centre , Human Research Ethics Committee , Development Rd Expenses , Professor Rodney Hicks , Dose Escalation Trial , Fifth Dose Level Cohort , Fourth Quarter , Year Ended December , Private Securities Litigation Reform Act , Professor Hicks , Financial Officer ,

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kimr Tsuchimoto , Rodney Hicks , Monopartx Linkedin , Chandler Robinson , Precision Molecular Imaging Theranostics Pty Ltd , Society Of Nuclear Medicine , Melbourne Theranostic Innovation Centre , Cancer Imaging At Peter Maccallum Centre , Monopar Therapeutics Inc , Exchange Commission , Professor Rodney Hicks , Siemens Biograph Vision Quadra , Professor Hicks , Chief Executive , Chief Medical Officer , Board Chair , Precision Molecular Imaging , Theranostics Pty Ltd , Cancer Imaging , Peter Maccallum Centre , Saul Hertz Award , Nuclear Medicine , Molecular Imaging , Private Securities Litigation Reform Act , Financial Officer ,